DTIL (Precision BioSciences) Tariff Resilience Score: 6/10 (As of Jul. 11, 2026)


DTIL Precision BioSciences Inc DTIL
50 GF Score
Price $8.77
GF Value $1.83
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Precision BioSciences Tariff Resilience Score?

Precision BioSciences DTIL -4.37% 50 Tariff Resilience Score is 6 as of Jul. 11, 2026. GuruFocus rates DTIL with a GF Score™ of 50/100 and a GF Value™ of $1.83 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 1,369 Biotechnology companies, Precision BioSciences ranks better than 75.97% on this metric.

Precision BioSciences has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Precision BioSciences has Precision BioSciences operates in the biotech sector, which is less affected by tariffs. However, it sources some materials internationally, exposing it to potential tariff impacts. The company has moderate pricing power and can explore alternative suppliers.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Precision BioSciences might have Average Resilient.

Precision BioSciences  (NAS:DTIL) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Precision BioSciences Tariff Resilience Score Related Terms

DTIL vs NBP, HUMA, ORMP: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Precision BioSciences's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Precision BioSciences Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Precision BioSciences's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Precision BioSciences's Tariff Resilience Score falls into.


DTIL
50GF Score
Precision BioSciences Inc DTIL
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Precision BioSciences (DTIL) has a Tariff Resilience Score of 6 as of Jul. 11, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Precision BioSciences ranks #329 out of 1369 companies in the Biotechnology industry, placing it in the top 24%.
Is Precision BioSciences' Tariff Resilience Score too high?
Precision BioSciences' current Tariff Resilience Score is 6. The Biotechnology industry median Tariff Resilience Score is 4.00. Precision BioSciences' value of 6 is 50% above this industry median. Based on the distribution chart, Precision BioSciences ranks #329 out of 1369 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Precision BioSciences has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Precision BioSciences' Tariff Resilience Score compare to NBP and HUMA?
According to the Biotechnology industry distribution chart, Precision BioSciences ranks #329 out of 1369 companies for Tariff Resilience Score. This places Precision BioSciences in the top 24% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. Precision BioSciences' value of 6 is 50% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,369 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Precision BioSciences's current Tariff Resilience Score of 6 is 50% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Precision BioSciences's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Precision BioSciences stock overvalued right now?
Based on GuruFocus' analysis, Precision BioSciences (DTIL) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.83, compared to a current price of $8.77 — trading 379% above its estimated fair value. The current Tariff Resilience Score is 6 and 50% above the Biotechnology industry median of 4.00. Precision BioSciences' overall GF Score™ is 50/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Precision BioSciences (DTIL), the current Tariff Resilience Score is 6 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Precision BioSciences (DTIL) Overvalued in 2026?

Based on GuruFocus' analysis, Precision BioSciences stock appears to be overvalued. The current stock price of $8.77 is trading 379% above its estimated GF Value™ of $1.83. GuruFocus considers Precision BioSciences to be Significantly Overvalued.

Key valuation signals for DTIL:

  • Tariff Resilience Score: 6
  • GF Value™: $1.83 vs. price of $8.77 (379% above fair value)
  • GF Score™: 50/100 with 5 warning signs
  • Industry Position: 50% above the Biotechnology median (#329 of 1369)

No single metric tells the full story. See the DTIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Precision BioSciences Business Description

Other Exchanges PBS0:Germany
Address 302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC, USA, 27701
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
50GF Score

Get the complete analysis for DTIL

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.77
Price
$1.83
GF Value